Indications for implantable cardioverter defibrillator (ICD) therapy

Europace

Volumn 3, Issue 3, 2001, Pages 169-176

  Hauer, R N W ^a   Aliot, E ^a   Block, M ^a   Capucci, A ^a   Luderitz B ^a   Santini, M ^a   Vardas, P E ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; PROCAINAMIDE; SOTALOL;

ARTICLE; CLINICAL TRIAL; CONGESTIVE CARDIOMYOPATHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEFIBRILLATION; DEFIBRILLATOR; HEART ARREST; HEART ARRHYTHMIA; HEART PACING; HEART RIGHT VENTRICLE DYSPLASIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; IDIOPATHIC DISEASE; LONG QT SYNDROME; MITRAL VALVE PROLAPSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYMPATHECTOMY; TREATMENT INDICATION; VALVULAR HEART DISEASE;

ARRHYTHMIA; ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA; CARDIAC PACING, ARTIFICIAL; CARDIOMYOPATHY, DILATED; CARDIOMYOPATHY, HYPERTROPHIC; CORONARY ARTERIOSCLEROSIS; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; EUROPE; HEART VALVE DISEASES; HUMANS; RANDOMIZED CONTROLLED TRIALS;

EID: 0034937333     PISSN: 10995129     EISSN: None     Source Type: Journal    
DOI: 10.1053/eupc.2001.0179     Document Type: Article

References (58)

1. Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings
2. Randomized study of implantable defibrillator as first-choice therapy versus conventional strategy in postinfarct sudden death survivors
3. Cost-effectiveness of implantable defibrillator as first-choice therapy versus electrophysiologically guided, tiered strategy in postinfarct sudden death survivors: A randomized study
4. Improved survival with an implanted defibrillator in patients with prior myocardial infarction, low ejection fraction and asymptomatic nonsustained ventricular tachycardia
5. A comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from near fatal ventricular arrhythmias
6. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary artery bypass graft surgery
7. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest
8. A randomized trial of the implantable cardioverter defibrillator against amiodarone
9. A randomized study of the prevention of sudden death in patients with coronary artery disease
10. Idiopathic ventricular fibrillation
11. Unfavorable outcome in patients with primary electrical disease who survived an episode of ventricular fibrillation
12. Idiopathic ventricular fibrillation: Risk stratification and 24 months follow-up in 16 patients
13. Recommendations for qualification of centers implanting and following defibrillators
14. Diverse mechanisms of unexpected cardiac arrest in advanced heart failure
15. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Pacemaker Implantation)
16. Leitlinien zur Implantation von Defibrillatoren
17. Mortality in patients with implanted automatic defibrillators
18. Do patients with an implantable defibrillator live longer?
19. Influence of implantable cardioverter defibrillators on the long-term prognosis of survivors of out of hospital cardiac arrest
20. Comparison of d,1 sotalol and implantable defibrillators for treatment of sustained ventricular tachycardia or fibrillation in patients with coronary artery disease
21. Prospective, double-blind, placebo-controlled trial of low-dose amiodarone in patients with severe heart failure and asymptomatic frequent ventricular ectopy
22. Dilated cardiomyopathies of the adult (first of two parts)
23. Outcome of patients with non-ischemic dilated cardiomyopathy and unexplained syncope treated with an implantable cardioverter defibrillator
24. Electrophysiological evaluation of sustained ventricular tachyarrhythmias in idiopathic dilated cardiomyopathy
25. Potential benefit from ICD therapy in patients with and without heart failure
26. Arrhythmia and prognosis in infants, children and adolescents with hypertrophic cardiomyopathy
27. Hypertrophic cardiomyopathy and sudden death
28. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy
29. Mitral valve prolapse
30. Idiopathic long QT syndrome: Progress and questions
31. Genetic and molecular basis of cardiac arrhythmias: Impact on clinical management
32. Effectiveness and limitations of β-blocker therapy in congenital long-QT syndrome
33. Survivors of out of hospital cardiac arrest with apparently normal heart: Need for definition and standardized clinical evaluation. Consensus statement of the Joint Steering Committees of UCARE and of IVF-US
34. Right bundle branch block, persistent ST-segment elevation and sudden cardiac death: A distinct clinical and electrocardiographic syndrome: A multicenter report
35. Implantable cardioverter defibrillators: Clinical aspects
36. Ventricular arrhythmias detected after transvenous defibrillator implantation in patients with a clinical history of only ventricular fibrillation: Implications for use of implantable defibrillator
37. Characterization of spontaneous recurrent ventricular arrhythmias detected by electrogram-storing defibrillators in sudden cardiac death survivors with no inducible ventricular arrhythmias at baseline electrophysiologic testing
38. Efficacy of antitachycardia pacing in patients with cardiac arrest
39. Arrhythmia recurrence in patients with a healed myocardial infarction who received an implantable defibrillator: Analysis according to the clinical presentation
40. Adverse events with transvenous inplantable cardioverter-defibrillators: A prospective multicenter study
41. Discrimination of ventricular tachycardia from sinus tachycardia and atrial fibrillation in a tiered-therapy cardioverter-defibrillator
42. Programmable VT detection enhancements in implantable cardioverter defibrillator therapy
43. Enhanced detection criteria in implantable cardioverter-defibrillators to avoid inappropriate therapy
44. Enhanced detection criteria in implantable defibrillators
45. Efficacy and safety of the initial use of stability and onset criteria in implantable cardioverter defibrillator
46. Worldwide experience with the electrogram width feature for improved detection in an implantable pacer-cardioverter-defibrillator
47. The potential for inappropriate ventricular tachycardia confirmation using the Intracardiac Electrogram (EGM) Width Criterion
48. First results with a new morphology criterion for discrimination of supraventricular and ventricular tachycardias
49. Preliminary clinical experience with the first dual chamber pacemaker defibrillator
50. Experience with a new dual chamber implantable defibrillator
51. Empirical versus tested antitachycardia pacing in implantable cardioverter defibrillators: A prospective study including 200 patients
52. Cardiac pacing in the long QT syndrome: Review of available data and practical recommendations
53. First results of the Prevent study
54. Acute hemodynamic effects of biventricular DDD pacing in patients with end-stage heart failure
55. Effect of pacing chamber and atrioventricular delay on acute systolic function of paced patients with congestive heart failure
56. Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy. A randomized, double-blind, crossover study (M-PATHY)
57. Significant improvement of quality of life following atrioventricular synchronous pacing in patients with hypertrophic obstructive cardiomyopathy. Data from 1 year of follow-up. PIC study group. Pacing in cardiomyopathy
58. Detection of atrial fibrillation and flutter by a dual-chamber implantable cardioverter-defibrillator